SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : BIKO: BICO

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: n540jb who wrote (13)8/2/2001 9:52:47 AM
From: REH   of 28
 
BICO Reports No Operational Reason for Stock Drop
PITTSBURGH, Aug. 2 /PRNewswire/ -- BICO, Inc. (OTC Bulletin Board: BIKO) today announced in response to the recent drop in its stock price that nothing material to the Company's operations has occurred to cause such a decline. In fact, BICO's consolidated revenues are currently exceeding all historical results.

Led by Petrol Rem, BICO's environmental clean-up subsidiary, BICO anticipates that revenues will continue to increase during the third quarter. Further, BICO recently announced the acquisition of the exclusive worldwide marketing rights to the InstantScreen(R) Rapid HIV 1/2 test that shows 100% specificity and sensitivity in preliminary reports from Walter Reed Army Hospital evaluations. Biocontrol Technology, the Indiana, PA-based division, recently received what it hopes will be the first in a series of outside manufacturing contracts which will utilize their facility to generate revenue while clinical trials of the noninvasive glucose sensor continue. Subsidiary ViaCirq is generating revenue and continues to place its Thermo-Chem(TM) HT System at additional major health care institutions pursuant to evaluation agreements, which ViaCirq believes will result in sales of its extracorporeal hyperthermia equipment and disposables.

BICO, Incorporated has its corporate offices in Pittsburgh, PA and is involved in the development and manufacture of biomedical devices and environmental solutions.

FOR FURTHER INFORMATION, CONTACT:
Investors Media
Diane McQuaide Susan Taylor
1.412.429.0673 phone 1.412.429.0673 phone
1.412.279.9690 fax 1.412.279.5041 fax

INVESTOR RELATIONS NEWSLINE NUMBER: 1.800.357.6204
WEBSITE - www.bico.com

This press release contains statements of a forward-looking nature. Shareholders and potential investors are cautioned that such statements are predictions and actual events or results may vary significantly.

MAKE YOUR OPINION COUNT - Click Here tbutton.prnewswire.com

SOURCE BICO, Incorporated

/CONTACT: Investors, Diane McQuaide, +1-412-429-0673, or fax,
+1-412-279-9690, or media, Susan Taylor, +1-412-429-0673, or fax,
+1-412-279-5041, both for BICO/

/Web site: bico.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext